1. Academic Validation
  2. Ginsenoside Rb1 Alleviated High-Fat-Diet-Induced Hepatocytic Apoptosis via Peroxisome Proliferator-Activated Receptor γ

Ginsenoside Rb1 Alleviated High-Fat-Diet-Induced Hepatocytic Apoptosis via Peroxisome Proliferator-Activated Receptor γ

  • Biomed Res Int. 2020 Jul 13;2020:2315230. doi: 10.1155/2020/2315230.
Bing Song 1 Yao Sun 2 Yafen Chu 3 Jing Wang 1 Hongwei Zheng 1 Lili Liu 1 Wang Cai 4 Haoqiang Zhang 5
Affiliations

Affiliations

  • 1 Department of Endocrinology, First Affiliated Hospital of Jinzhou Medical University, China.
  • 2 Department of Pharmacy, Taikang Xianlin Drum Tower Hospital, Medical School of Nanjing University, China.
  • 3 Department of Endocrinology, Ningbo Medical Center Lihuili Hospital, China.
  • 4 Department of Obstetrics and Gynecology, First Affiliated Hospital of Jinzhou Medical University, China.
  • 5 Department of Endocrinology, Affiliated Zhongda Hospital of Southeast University, China.
Abstract

Objective: High-fat-diet- (HFD-) induced hepatic cell Apoptosis is common in mice with nonalcoholic fatty liver disease (NAFLD). We aim to investigate the effect of Ginsenoside Rb1 (GRb1) on hepatocyte Apoptosis.

Methods: C57BL/6J mice with HFD were used to induce a liver-injured model with cell Apoptosis. In addition, GRb1 was used to treat HFD-induced Apoptosis in a liver with or without inhibitor of Peroxisome Proliferator-activated Receptor γ (PPAR-γ).

Results: Compared with C57BL/6J mice with common chow, there are downregulated PPAR-γ but upregulated cell Apoptosis in the liver of mice with HFD. Furthermore, GRb1 elevated the hepatic PPAR-γ level and suppressed hepatocytic Apoptosis. However, GW9662 abolished the effects of GRb1 on Apoptosis in the liver.

Conclusions: GRb1 alleviated HFD-induced Apoptosis of hepatocytes of mice via PPAR-γ.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-16578
    99.87%, PPARγ Antagonist